ZA897618B - Antimalarial compositions and methods of treatment using quinidine,artemisinine and its derivates - Google Patents

Antimalarial compositions and methods of treatment using quinidine,artemisinine and its derivates

Info

Publication number
ZA897618B
ZA897618B ZA897618A ZA897618A ZA897618B ZA 897618 B ZA897618 B ZA 897618B ZA 897618 A ZA897618 A ZA 897618A ZA 897618 A ZA897618 A ZA 897618A ZA 897618 B ZA897618 B ZA 897618B
Authority
ZA
South Africa
Prior art keywords
artemisinine
quinidine
derivates
treatment
methods
Prior art date
Application number
ZA897618A
Other languages
English (en)
Inventor
Deepak Kumar Chatterjee
Kumar Chatterjee Deepak
Bindumadhavan Venugopalan
Venugopalan Bindumadhavan
Juergen Blumbach
Blumbach Juergen
Subramani Natrajan Iyer
Natrajan Iyer Subramani
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA897618B publication Critical patent/ZA897618B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA897618A 1988-10-07 1989-10-06 Antimalarial compositions and methods of treatment using quinidine,artemisinine and its derivates ZA897618B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88116605 1988-10-07

Publications (1)

Publication Number Publication Date
ZA897618B true ZA897618B (en) 1990-06-27

Family

ID=8199431

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA897618A ZA897618B (en) 1988-10-07 1989-10-06 Antimalarial compositions and methods of treatment using quinidine,artemisinine and its derivates

Country Status (10)

Country Link
EP (1) EP0362810B1 (fr)
JP (1) JPH02157223A (fr)
KR (1) KR900005978A (fr)
CN (1) CN1041694A (fr)
AU (1) AU4263789A (fr)
DE (1) DE68906345T2 (fr)
ES (1) ES2054975T3 (fr)
MX (1) MX17877A (fr)
NZ (1) NZ230926A (fr)
ZA (1) ZA897618B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166154B (fr) * 1987-05-08 1990-03-24 Hoechst India
CN1058717A (zh) * 1990-08-08 1992-02-19 中国人民解放军军事医学科学院微生物流行病研究所 抗疟新药—复方蒿甲醚及其制备方法
US5637594A (en) * 1991-04-11 1997-06-10 Ciba Geigy Corporation Antimalarial synergistic compositions containing benflumetol
NZ246606A (en) * 1992-02-07 1995-09-26 Ciba Geigy Ag Antimalarial compostions containing a synergistic combination of benflumetol and quinine or a derivative thereof
CH692321A5 (de) * 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
CN1081035C (zh) * 1997-11-18 2002-03-20 广州市健桥医药科技发展有限公司 抗疟疾新药复方萘酚喹
CN1109546C (zh) * 1998-06-17 2003-05-28 中国疾病预防控制中心寄生虫病预防控制研究所 青蒿素类药物与咯萘啶的复方制剂抗疟药物
EP0974594A1 (fr) * 1998-07-14 2000-01-26 The Hong Kong University of Science & Technology Dérivés d'artémisinine comme agent anti-infectieux
WO2001072304A1 (fr) * 2000-03-28 2001-10-04 Council Of Scientific And Industrial Research Nouvelle composition antimicrobienne et procede de production de celle-ci
AU2000255631A1 (en) * 2000-03-31 2001-10-15 Council Of Scientific And Industrial Research A synergistic anti-malarial formulation
AU2001295979A1 (en) * 2000-10-20 2002-04-29 Ajinomoto Co., Inc. Medicinal compositions, dose and method for treating malaria
US20050148628A1 (en) * 2002-02-13 2005-07-07 Edgar Muller Pharmaceutical combination of artesunate and mefloquine for therapy of malaria
WO2005023304A2 (fr) * 2003-09-04 2005-03-17 Cipla Limited Compositions antipaludeennes et procede associe
BRPI0401107A (pt) * 2004-04-13 2005-11-22 Fundacao Oswaldo Cruz Compostos derivados de artesunato, processo de preparação destes compostos, composição farmacêutica contendo os ditos compostos, uso do respectivo medicamento no tratamento ou prevenção da malária ou outras doenças parasitárias e método terapêutico
CH700941B1 (de) * 2007-12-04 2010-11-15 Mepha Ag Pharmazeutische Zusammensetzung zur Behandlung von Malaria.
WO2013095215A1 (fr) * 2011-12-19 2013-06-27 Dilaforette Ab Héparines anticoagulantes de faible poids moléculaire
EP2929881A1 (fr) * 2014-04-11 2015-10-14 CeMM - Forschungszentrum für Molekulare Medizin GmbH Utilisation médicale de composés d'artémisinine et agonistes de géphyrine
CN110691597A (zh) 2017-04-24 2020-01-14 诺华股份有限公司 2-氨基-1-(2-(4-氟苯基)-3-(4-氟苯基氨基)-8,8-二甲基-5,6-二氢咪唑并[1,2-a]吡嗪-7(8H)-基)乙酮及其组合的治疗方案
WO2023107640A1 (fr) * 2021-12-09 2023-06-15 Incarda Therapeutics, Inc. Thérapie inhalée pour arythmie cardiaque

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166154B (fr) * 1987-05-08 1990-03-24 Hoechst India

Also Published As

Publication number Publication date
MX17877A (es) 1993-11-01
EP0362810A1 (fr) 1990-04-11
ES2054975T3 (es) 1994-08-16
AU4263789A (en) 1990-04-12
KR900005978A (ko) 1990-05-07
CN1041694A (zh) 1990-05-02
EP0362810B1 (fr) 1993-05-05
NZ230926A (en) 1992-02-25
JPH02157223A (ja) 1990-06-18
DE68906345D1 (de) 1993-06-09
DE68906345T2 (de) 1993-10-28

Similar Documents

Publication Publication Date Title
ZA897618B (en) Antimalarial compositions and methods of treatment using quinidine,artemisinine and its derivates
EP0491861A4 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
ZA915371B (en) Antitumor compositions and methods of treatment
AU1520188A (en) Compositions and methods of treatment of timber
GB2225787B (en) Compositions and process for the treatment of textiles
AU581853B2 (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer
EP0313654A4 (fr) Medicament pour la prophylaxie et le traitement de l'hepatopathie.
EP0332657A4 (fr) Compositions anti-malaria et procedes.
ZA909085B (en) Treatment of depression
EP0257616A3 (en) Dihydropyridine derivates and pharmaceutical composition thereof
AU3553489A (en) Novel compounds and treatment
EP0411900A3 (en) Treatment of conditions involving excessive eating
IL90280A0 (en) Copolymers,coatings containing them and the preparation of such coatings
GB2220652B (en) Treatment of pastures
EP0427458A3 (en) Use of heptapeptides in the treatment or prophylaxis of muscle wasting
EP0393339A3 (en) Preparation of pre-caseinates, and use
AU4102789A (en) Treatment compositions
AU8094887A (en) Water treatment compositions and processes
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
GB8908866D0 (en) Pharmaceutical compositions and treatment
GB8805885D0 (en) Treatment of onions
ZA909765B (en) Vitamin-mineral treatment methods and compositions
GB8908023D0 (en) Therapeutic compounds,compositions and uses thereof
AU680568B2 (en) Vitamin-mineral treatment methods and compositions